This American Heart Month is a time to spread awareness about heart health and diagnoses that can be easy to miss. One of those diagnoses is Atrial Fibrillation.

Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry.

Patients living with Atrial Fibrillation, or AFib, are typically prescribed an anticoagulant – blood thinner medication – to reduce the risk of stroke. However, some patients may soon be able to ...

Abbott’s Volt pulsed-field ablation (PFA) system will be trialled across 15 NHS sites for the treatment of atrial fibrillation.

It is estimated that about 1.5 million people in the UK have the condition which can put patients at higher risk of stroke ...

NEW YORK — Daniel Moore was about 30 the first time it happened. At the end of a long, hot, stressful day, he chugged an ice-cold glass of milk. “It felt like a bunny rabbit trying to jump out of my ...

Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation ...

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients ...

Twelve-month data from the VOLT-AF Global IDE study found that the Volt PFA System had an industry-leading success rate (84.2%) of freedom from documented rhythm recurrence among all competitive PFA ...